This Quality Improvement (QI) Program aims to improve the management of patients with chronic heart failure with a LVEF (left ventricular ejection fraction) lower than 40%.
This Quality Improvement (QI) program aims to optimise pharmacological and non-pharmacological management of lipid abnormalities in patients with atherogenic dyslipidaemia, to achieve a reduction in cardiovascular disease risk in patients.
Insomnia is the most common sleep disorder seen in primary care, accounting for 8 out of 10 sleep disorders. Australian population surveys show that up to one third of adults have regular difficulty in getting to sleep or staying asleep. Despite its frequent presentation, the management of insomnia is said to be suboptimal due to under recognition of the disorder as well as inadequate treatment strategies. This activity will help GPs understand the impact of insomnia, how to identify insomnia and how to approach treatment.
This ALM covers three key aspects of women's health: breast cancer, heavy menstrual bleeding and cervical cancer. Screening and management methods in light of the latest clinical guidelines are explored, as well as effective management methods and when to refer patients to specialists.
Chronic non-cancer pain can have significant effects on a patient's physical and psychological wellbeing, and requires multimodal and multidisciplinary management approaches tailored to the individual patient. This module explores the process of creating individualised management plans using non-pharmacological and pharmacological approaches where appropriate.
It's Kidney Health Week! Read on to hear from Dr Shilpa Jesudason & Breonny Robson, as they encourage all primary healthcare workers to open their eyes to Chronic Kidney Disease (CKD), an often under-diagnosed condition that currently affects almost 2 million Australians.
Heart failure is a significant health issue in Australia, with complex diagnostic and management methods that must be tailored to each patient. This ALM comprehensively covers the many stages of heart failure management including the identification of risk factors, diagnosis and investigations, pharmacological and non-pharmacological management, management of progression and comorbidities, the use of implantable devices and end-of-life care, and multidisciplinary care programs.